ML18346A370

From kanterella
Jump to navigation Jump to search
Dtab 2018 December NRC FFD Performance 2017
ML18346A370
Person / Time
Issue date: 12/04/2018
From: Harris P
NRC/NSIR/DPCP/FCTSB
To:
References
Download: ML18346A370 (15)


Text

Presentation to the Drug Testing Advisory Board (HHS/SAMHSA)

Drug Testing at Commercial Nuclear Power Plants and Fuel Facilities 10 CFR Part 26, Fitness-for-Duty Programs A Direct Contribution to Safety and Security December 4, 2018

Disclaimer The information in this presentation is provided as a public service and solely for informational purposes and is not, nor should be deemed as, an official NRC position, opinion or guidance, or "a written interpretation by the General Counsel" under 10 CFR 26.7, on any matter to which the information may relate. The opinions, representations, positions, interpretations, guidance or recommendations which may be expressed by the NRC technical staff during this presentation or responding to an inquiry are solely the NRC technical staff's and do not necessarily represent the same for the NRC. Accordingly, the fact that the information was obtained through the NRC technical staff will not have a precedential effect in any legal or regulatory proceeding.

Slide 2

Discussion Topics Slide 3 Fitness-for-Duty (FFD) Program Objective Individuals covered by the FFD Program FFD Program Elements Assuring Safety and Security through a Defense-in-Depth Strategy FFD Performance Industry Activities/Initiatives

FFD Program Objective Provide reasonable assurance that nuclear power plant personnel are trustworthy, reliable, and not under the influence of any substance, legal or illegal, or mentally or physically impaired from any cause, which in any way adversely affects their ability to safely and competently perform assigned duties or be afforded unescorted access to the protected areas of nuclear power plants, sensitive information, or strategic special nuclear material (SSNM).

Slide 4 An FFD program developed under Part 26 is intended to create an environment which is free of drugs and alcohol, and the effects of such substances.

Individuals Covered by the FFD Program Slide 5 Security Control Room Operators Maintenance & Surveillance (craft & supervisors)

Health Physics, Chemistry, & Emergency Response Construct or Direct the Construction of Reactor Plants All other persons who have unescorted access FFD Program Personnel*

Slide 5

  • FFD Program Personnel include the managers, technicians, collectors, Medical Review Officers, and Substance Abuse Experts who implement the program Fit for Duty Reliable Trustworthy

Assuring Safety and Security through a Defense-in-Depth Strategy Slide 6 People Education, experience, training, qualification, etc.

Drug and Alcohol Testing (pre-access, random, for-cause, followup, and post-event)

Behavioral Observation Fatigue Management Access Requirements (e.g., background checks, fingerprinting, psychological testing)

Physical Protection (e.g., vehicle barriers, blast walls, blast resistant enclosures, etc.)

Detection (e.g., cameras, infra-red, motion, explosive vapors, x-ray, etc.)

Programs for Insider Mitigation, Cyber Protection, and Information Controls

FFD Program Personnel include the managers, technicians, collectors, Medical Review Officers, and Substance Abuse Experts who implement the program All results in this presentation are Medical Review Officer verified Overall Industry Performance, 2017

[Draft]

148,357 Individuals drug & alcohol tested 1,143 Individuals tested positive for a drug, alcohol, or refused a test 2/3 identified prior to entering the facility - pre-access testing 1/3 identified inside the facility - primarily by random testing 0.44%

Random positive rate 0.77%

Overall positive rate Observations Contractor/vendors still testing 3-4x higher than licensee employees Subversion attempts continue to be identified FFD program personnel remain the Silent Heroes of our program Slide 7 Slide 7

Results by Test and Employment Categories, 2017

[DRAFT]

Slide 8 Tested Positive Percent Positive Tested Positive Percent Positive Tested Positive Percent Positive Pre-Access 8,513 36 0.42%

71,586 695 0.97%

80,099 731 0.91%

64.0%

Random 34,624 48 0.14%

25,100 212 0.84%

59,724 260 0.44%

22.7%

For Cause 111 14 12.61%

757 64 8.45%

868 78 8.99%

6.8%

Post-Event 136 0.00%

492 11 2.24%

628 11 1.75%

1.0%

Followup 3,044 13 0.43%

3,994 50 1.25%

7,038 63 0.90%

5.5%

Total 46,428 111 0.24%

101,929 1,032 1.01%

148,357 1,143 0.77%

100.0%

Test Category Licensee Employees Contractor/Vendors (CVs)

Total

% of Total Positives Where were the most tests conducted in 2017 (>90% of tests)?

Licensee Employees Contractor/Vendors Pre-access 18.3%

Pre-access 70.2%

Random 74.6%

Random 24.6%

Followup 6.6%

Followup 3.9%

99.5%

98.8%

Where were most drug and alcohol testing violations identified in 2017 (>90% of positives)?

Licensee Employees Contractor/Vendors Pre Access 32.4%

Pre-access 67.3%

Random 43.2%

Random 20.5%

For Cause 12.6%

For Cause 6.2%

Followup 11.7%

94.1%

100.0%

Slide 8

Detection Trends - NRC Testing Panel Percentage of Total Positives by Substance Tested

[Draft]

Slide 8 marijuana cocaine alcohol amphetamines opiates PCP 0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Percent of Total Positives Since at least 2014, this chart under reports the substances used by individuals with a drug testing violation. This is because of the high number of subversion attempts each year, and because in at least 60% of these subversion attempts, no specimens were tested.

Slide 9

Results by Employment Category, 2017

[DRAFT]

Licensee Employees (46,428 tested; 111 individuals positive)

Contractors/Vendors (101,929 tested; 1,032 individuals positive)

Marijuana 39.9%

Alcohol 16.4%

Refusal to Test 19.2%

Cocaine 12.3%

Amphetamines 10.8%

Opiates 1.2%

Other 0.2%

PCP 0.1%

n = 1,096 Marijuana 34.5%

Alcohol 35.3%

Refusal to Test 2.5%

Cocaine 11.8%

Amphetamines 13.4%

Opiates 0.8%

Other 1.7%

n = 119 Slide 10

Additional Substance Test Results, 2011-2017

[Draft]

Slide 12 2011 2012 2013 2014 2015 2016 2017 Total Benzodiazepines 1

2 1

1 1

1 7

Buprenorphine 1

1 1

3 Fentanyl 1

1 Hydrocodone 1

1 1

3 Hydromorphone 1

1 2

Methadone 1

1 1

1 4

Norbuprenorphine 1

1 Oxycodone 1

1 1

1 4

Oxymorphone 1

1 1

1 4

Propoxyphene 1

1 Tramadol 1

1 Total 2

6 4

7 7

1 4

31 The 31 test results in this table reflect positive results for 24 individuals. That is, some individuals tested positive for more than one of the substances in the same testing event Slide 11

Additional Substance Results by Test Category (2011-2017) [Draft]

Slide 13 66% of individuals (16 of 24) tested positive on for-cause testing 25% of individuals (6 of 24) tested positive for one or more of the semi-synthetic opiates in the updated HHS Guidelines (i.e., hydrocodone, hydromorphone, oxycodone, oxymorphone) 57% of individuals that tested positive for an additional substance, also tested positive for a substance in the NRC-required testing panel (i.e., amphetamine, methamphetamine, cocaine, marijuana)

Substances Pre-Access Random For Cause Followup Total Amphetamine; Marijuana; Hydrocodone; Hydromorphone 1

1 Amphetamine; Methamphetamine; Marijuana; Benzodiazepines 1

1 Amphetamine; Methamphetamine; Benzodiazepines 2

2 Amphetamine; Methamphetamine; Hydrocodone; Hydromorphone 1

1 Benzodiazepines 1

1 2

4 Buprenorphine 1

1 Buprenorphine; Norbuprenorphine 1

1 Cocaine; Benzodiazepines 1

1 Fentanyl; Oxycodone; Oxymorphone 1

1 Hydrocodone 1

1 Hydrocodone; Oxycodone; Oxymorphone 1

1 Marijuana; Benzodiazepines 1

1 Marijuana; Benzodiazepines; Methadone 1

1 Marijuana; Propoxyphene 1

1 Methadone 1

1 2

Oxycodone; Oxymorphone 2

2 Tramadol 2

2 Total 4

2 16 2

24 Slide 12

Subversion Attempt Trends [Draft]

Subversion attempt - any willful act or attempted act to cheat on a required test (e.g., refuse to provide a specimen, alter a specimen with an adulterant, provide a specimen that is not from the donors body)

Sanction for a subversion attempt: Permanent denial of unescorted access (10 CFR 26.75)

Slide 13 Subversion Attempt Trends 2012 - 177 of 1,114 violations (15.8% subversions) 2013 - 148 of 1,007 violations (14.7% subversions) 2014 - 187 of 1,133 violations (16.5% subversions) 2015 - 232 of 1,200 violations (19.3% subversions) 2016 - 304 of 1,164 violations (26.1% subversions) 2017 - 298 of 1,143 violations (26.1% subversions)

Subversion Attempts in 2017 45 facilities with at least 1 subversion attempt 67% identified at Pre-Access testing (200 of 298) 98% by contractor/vendors Slide 13

Industry Activities/Initiatives Slide 14 Oral fluid testing Expanded panel testing Auditing of HHS-certified laboratories Background checks and true identity determinations Slide 14

NRC Fitness for Duty Program Staff Slide 15 U.S. Nuclear Regulatory Commission Office of Nuclear Security and Incident Response Paul Harris, Senior Program Manager Paul.Harris@nrc.gov (301-287-9294)

Brian Zaleski, Fitness-for-Duty Program Specialist Brian.Zaleski@nrc.gov (301-287-0638)